Report post
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the Taiwan Food and Drug Administration …

Related articles

The World's Leading Crypto Trading Platform

Get my welcome gifts